TCBPW Total Assets from 2010 to 2024

TCBPW Stock

USD 0.02 0.0005 3.03%

TC BioPharm Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

8.9 M

Current Value

10 M

Quarterly Volatility

991.7 K

Credit Downgrade

Yuan Drop

Covid

Check TC BioPharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TC BioPharm's main balance sheet or income statement drivers, such as Interest Income of 1.9 K, Depreciation And Amortization of 638 K or Interest Expense of 78.9 K, as well as many indicators such as Price To Sales Ratio of 0.62, Dividend Yield of 0.0 or PTB Ratio of 0.3. TCBPW financial statements analysis is a perfect complement when working with TC BioPharm Valuation or Volatility modules.

Check out the analysis of TC BioPharm Correlation against competitors.

Latest TC BioPharm's Total Assets Growth Pattern

Below is the plot of the Total Assets of TC BioPharm plc over the last few years. Total assets refers to the total amount of TC BioPharm assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in TC BioPharm plc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. TC BioPharm's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TC BioPharm's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 8.93 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

TCBPW Total Assets Regression Statistics

	Arithmetic Mean	9,797,057
	Geometric Mean	9,744,816
	Coefficient Of Variation	10.12
	Mean Deviation	689,236
	Median	10,139,816
	Standard Deviation	991,665
	Sample Variance	983.4B
	Range	4M
	R-Value	(0.31)
	Mean Square Error	957.3B
	R-Squared	0.1
	Significance	0.26
	Slope	(68,730)
	Total Sum of Squares	13.8T

TCBPW Total Assets History

	2024	10 M
	2023	8.9 M
	2022	11.3 M
	2021	8 M
	2020	7.3 M

Other Fundumenentals of TC BioPharm plc

Intangibles To Total Assets

TC BioPharm Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Short Long Term Debt
Total Assets		0.47	0.05	-0.49	0.23	-0.38	0.6	-0.26	0.41	0.62	0.18	0.53	-0.46	-0.3	0.53	-0.15
Total Stockholder Equity	0.47		-0.54	-0.97	-0.1	-0.03	0.02	-0.96	0.96	0.44	-0.03	0.9	-0.89	0.15	0.0	-0.55
Current Deferred Revenue	0.05	-0.54		0.43	0.85	-0.78	0.68	0.49	-0.74	-0.53	0.81	-0.15	0.12	-0.81	0.71	0.91
Net Debt	-0.49	-0.97	0.43		0.06	0.13	-0.01	0.94	-0.91	-0.47	-0.02	-0.87	0.88	-0.15	0.0	0.53
Retained Earnings	0.23	-0.1	0.85	0.06		-0.88	0.87	0.06	-0.37	-0.54	0.99	0.34	-0.35	-0.96	0.91	0.87
Accounts Payable	-0.38	-0.03	-0.78	0.13	-0.88		-0.76	0.0	0.22	0.39	-0.9	-0.39	0.43	0.86	-0.78	-0.68
Net Receivables	0.6	0.02	0.68	-0.01	0.87	-0.76		0.06	-0.2	-0.18	0.81	0.41	-0.36	-0.92	0.99	0.67
Total Liab	-0.26	-0.96	0.49	0.94	0.06	0.0	0.06		-0.9	-0.3	-0.03	-0.87	0.88	-0.17	0.05	0.48
Net Invested Capital	0.41	0.96	-0.74	-0.91	-0.37	0.22	-0.2	-0.9		0.58	-0.31	0.74	-0.72	0.4	-0.23	-0.75
Total Current Assets	0.62	0.44	-0.53	-0.47	-0.54	0.39	-0.18	-0.3	0.58		-0.58	0.15	-0.1	0.54	-0.26	-0.78
Capital Stock	0.18	-0.03	0.81	-0.02	0.99	-0.9	0.81	-0.03	-0.31	-0.58		0.4	-0.43	-0.94	0.86	0.83
Net Working Capital	0.53	0.9	-0.15	-0.87	0.34	-0.39	0.41	-0.87	0.74	0.15	0.4		-0.99	-0.3	0.41	-0.13
Short Term Debt	-0.46	-0.89	0.12	0.88	-0.35	0.43	-0.36	0.88	-0.72	-0.1	-0.43	-0.99		0.28	-0.37	0.11
Intangible Assets	-0.3	0.15	-0.81	-0.15	-0.96	0.86	-0.92	-0.17	0.4	0.54	-0.94	-0.3	0.28		-0.94	-0.87
Common Stock	0.53	0.0	0.71	0.0	0.91	-0.78	0.99	0.05	-0.23	-0.26	0.86	0.41	-0.37	-0.94		0.72
Short Long Term Debt	-0.15	-0.55	0.91	0.53	0.87	-0.68	0.67	0.48	-0.75	-0.78	0.83	-0.13	0.11	-0.87	0.72

Click cells to compare fundamentals

About TC BioPharm Financial Statements

TC BioPharm investors use historical fundamental indicators, such as TC BioPharm's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TC BioPharm. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	8.9 M	10 M
Intangibles To Total Assets	0.07	0.04

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for TCBPW Stock Analysis

When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC